| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |